Skip to main content
eScholarship
Open Access Publications from the University of California

UC San Diego

UC San Diego Electronic Theses and Dissertations bannerUC San Diego

Joint capture of engineered genomes, transcriptome effects, and off-target events in single cells

Abstract

Over the past decade, the fields of functional genomics and gene therapy have widely adopted a new method for modifying DNA called CRISPR-Cas9. For example, CRISPR screens are emerging as a pivotal tool for interrogating the mechanisms of non-coding sequences and genetic risk variants of disease. However, a longstanding barrier in genome engineering with CRISPR-Cas9 has been the inability to measure Cas9 edit outcomes and their functional effects at single-cell resolution. This dissertation presents two aims that address this barrier. The first aim applies a CRISPR tiling screen and secondary CRISPR deletion screen to map the cis-regulatory landscape of model genome locus GATA3 in human T cells. This aim reports novel functional enhancers that drive high GATA3 gene expression in primary Th2 cells, and identifies candidate causal risk variants of allergic disease that affect GATA3 activity. Additionally, this aim reveals the challenges of limited sensitivity and resolution that hamper current CRISPR screens. The second aim presents Superb-seq, a new technology that leverages T7 in situ transcription and single-cell RNA sequencing to jointly measure on- and off-target Cas9 edits and their effects on gene expression. Superb-seq was performed on 10,000 K562 cells, targeting four chromatin remodeler genes with seven guide RNAs. Superb-seq identified 11,891 edit events in 6,230 edited cells at all seven on-target sites and at an additional 36 off-target sites. Although the seven guides were selected for high specificity, six of them caused off-target edits, ranging in frequency from 0.03% to 18.6% of cells. A notable off-target edit within the first intron of USP9X disrupted the expression of this gene and over 150 downstream genes. This aim reveals that Cas9 off-targeting is a pervasive combination of rare and common edit events, occurs primarily within introns of off-target genes, and can exert widespread effects on gene expression. By using off-the-shelf kits, standard equipment, and requiring no virus, Superb-seq will enable genome-wide CRISPR screens in diverse cell types as well as functional characterization of therapeutic nucleases.

Main Content

This item is under embargo until July 2, 2027.